Dr Porters joins the division where he will be responsible for building medical capability across the Novartis Vaccines business, and will be closely involved with the implementation of Bexsero on the UK NIP.
Novartis Vaccines has named John Porter as Medical Affairs Director for Cluster North Europe
Dr Porters joins the division where he will be responsible for building medical capability across the Novartis Vaccines business, and will be closely involved with the implementation of Bexsero on the UK NIP.
Tags
Related posts
- Trial reveals mechanisms that contribute to impact of malnutrition and HIV infection
- Boehringer Ingelheim and Ochre Bio partner on liver disease in deal worth over $1bn
- New NIHR HRC launched for cardiovascular and respiratory medicine
- Study links dementia antipsychotics to higher risks of serious health outcomes
- New clinical trial aims to investigate skin patches to spot lung transplant rejection
